Case report
===========

A 68-year-old woman with known hypertension and osteoarthritis was found down in her residential complex and brought to the emergency department on 15 July 2011. On physical examination she was afebrile (36.1 °C), normotensive (107/43) and tachycardic (95 beats/min), with an oxygen saturation of 98% on room air. Swollen, erythematous lower extremities with areas of induration and scattered bullae were noted. Although initially alert and oriented, within 4 h she became difficult to arouse and was not following commands. Her neurological exam was non-focal, with pupils equally round and reactive to light, normal muscle tone and dull deep tendon reflexes. Initial laboratory findings were consistent with an anion-gap metabolic acidosis, acute renal failure, elevated liver enzymes and creatine phosphate kinase ([Table 1](#tbl1){ref-type="table"}). Head computed tomography imaging was unremarkable at the time of presentation. The patient was emergently intubated, and surgical exploration of her lower extremities was performed. No signs of necrotizing fasciitis were noted.

On post-operative reevaluation, the patient exhibited left horizontal gaze palsy, a left dilated non-reactive pupil, extensor Babinski response bilaterally and decerebrate posturing. Repeat head computed tomography imaging 20 h after the initial scan showed interval development of hydrocephalus requiring placement of an external ventricular drain. Interestingly, the initial cerebrospinal fluid (CSF) sample analysis on external ventricular drain placement yielded zero white blood cells, mildly elevated protein levels and normal glucose levels. However, Gram-negative rods were noted on microscopy (data not shown). Although she had already received doses of vancomycin, piperacillin-tazobactam, ceftriaxone and ampicillin by the end of day 1, the patient developed septic shock.

Within 24 h of admission, initial blood culture collected in emergency department, tissue and CSF cultures collected later were processed turned positive for the Gram-negative rod. Instead of waiting for another day for bacterial identification by using conventional culture method, the Gram-negative rod was identified as *Elizabethkingia meningosepticum* on the same day of positive culture by using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) Vitek mass spectrometry (VMS). The spectrum of VMS is shown in [Figure 1](#fig1){ref-type="fig"}. The patient\'s antimicrobial regimen was subsequently changed on the evening of hospital day 2, to levofloxacin 750 mg daily, trimethoprim-sulfamethoxazole 400 mg intravenous every 8 h, minocycline 100 mg every 12 h and rifampin 600 mg every 24 h. The regimen was derived from a review of the literature, 24 h prior to obtaining the conventional microbiological identification and sensitivities. The pathogen was susceptible to fluoroquinolones (minimal inhibitory concentration (MIC)≤1 µg/mL for ciprofloxacin and \<2 µg/mL for levofloxacin) and trimethoprim-sulfamethoxazole (MIC≤2--38 µg/mL), but was resistant to aminoglycosides, imipenem and piperacillin-tazobactam by using MicroScan WalkAway (Siemens, West Sacramento, CA, USA) with LabPro software and Clinical and Laboratory Standards Institute guidelines.^[@bib1]^ The patient\'s clinical status progressively improved, and within 72 h starting a tailored antibiotic regimen, her vital signs normalized.

Although this patient\'s initial neurological findings portended a poor prognosis, she exhibited early signs of neurological recovery with spontaneous movement of her extremities and head, eye tracking, as well as facial grimacing with withdrawal to pain. Magnatic resonance imaging of the brain performed on hospital day 6 revealed leptomeningeal enhancement compatible with a diagnosis of meningitis, but no other findings that could explain here neurological status. After a hospital course of 2 weeks, she was discharged to a long-term acute care hospital where she received 6 weeks of levofloxacin, minocycline and trimethoprim-sulfamethoxazole. By 8 weeks post-discharge, the patient had become alert and oriented and was actively participating in physical and occupational therapy, albeit with residual receptive aphasia.

Discussion
==========

*E. meningosepticum*, previously known as *Flavobacterium* and reclassified as *Chryseobacterium*,^[@bib2]^ was initially identified by Dr Elizabeth King as a causative agent of meningitis in neonates.^[@bib3]^ *E. meningosepticum* infections, whether in infants or adults, are mostly nosocomial, with less than 15% acquired in the community.^[@bib4],[@bib5]^ Case reports have described patients with endocarditis, cellulitis, necrotizing fasciitis, hepatitis, osteomyelitis and eye infections, in addition to the more common *E. meningosepticum* bacteremia and pneumonia.^[@bib4]^ The majority of infections in neonates present as meningitis. However, *E. meningosepticum* meningitis in adults is rare. Only 16 cases have been described worldwide; 15 of these cases described patients who had underlying comorbidities or who had undergone surgical procedures ([Table 2](#tbl2){ref-type="table"}).

*E. meningosepticum* is found ubiquitously in freshwater, saltwater and soil.^[@bib6]^ However, the majority of *E. meningosepticum* infections are nosocomial in origin.^[@bib4],[@bib5]^ As a biofilm-forming organism, it commonly colonizes sink drains and medical equipment such as ventilators, intravascular catheters and surgical tools, as well as solutions such as chlorhexidine.^[@bib7]^ Hospital isolates are thought to be the underlying cause of sporadic nosocomial outbreaks. Positive screening cultures should, however, be interpreted cautiously, as only 60% have shown clinical correlation with an infectious process.^[@bib5]^ Risk factors for *E. meningosepticum* infections relate to underlying immune dysfunction. In neonates, the main risk factor for *E. meningosepticum* infection is prematurity.^[@bib5]^ Most adults with *E. meningosepticum* meningitis suffer from comorbidities such as hematologic malignancies, diabetes or have recently undergone surgical procedures ([Table 2](#tbl2){ref-type="table"}). In two retrospective case studies of *E. meningosepticum* bacteremia, the most common comorbidities were cancer and diabetes mellitus.^[@bib4]^ Mortality rates in these patients are as high as 53%.^[@bib4],[@bib5]^ Although one case involved a 46-year-old man with no known underlying systemic disorder who succumbed to meningitis,^[@bib8]^ no immunologic evaluation was performed prior to his death. Our patient had regular follow-up visits with her primary care physician. Screening colonoscopy and mammogram were completed the year prior to presentation and were unremarkable. She had never been on corticosteroids. HIV antibody and a viral hepatitis panel were negative. Her hemoglobin A1C was 6.0%. Serum immunoglobulin and complement levels were within normal limits and anti-nuclear antibody screen was non-reactive. Thus, *E. meningosepticum* meningitis can occur in an immunocompetent host.

*E. meningosepticum*\'s unusual antimicrobial sensitivity is due to its production of two different metallo-β-lactamases, conferring the ability to degrade all β-lactam antibiotics.^[@bib9]^ Antibiotic susceptibility profiles vary across the reported literature^[@bib4],[@bib5]^ and thus, there is no consensus on appropriate therapy. The largest study examining 99 isolates and their susceptibilities to 19 antimicrobial agents suggested that *E. meningosepticum* is most sensitive to trimethoprim-sulfamethoxazole (91%), followed levofloxacin and moxifloxacin (81%--87%), doxycycline and piperacillin-tazopactam (78%).^[@bib4]^ The SENTRY report examining 24 isolates noted 87% susceptibility to rifampin.^[@bib10]^ Aminoglycosides and vancomycin have shown poor activity against *E. meningosepticum*.^[@bib4]^

The CSF findings in this case illustrate potential diagnostic challenges. Three out of 10 cases reporting CSF findings of adult patients with *E. meningosepticum* meningitis showed a paucity of CSF inflammation as low as 6 white blood cells (WBCs)/µL.^[@bib11]^ In this patient\'s case, there were 0 WBCs/µl in the initial CSF obtained during extra-ventricular drain insertion, despite positive Gram stain and culture. These findings show that meningitis caused by this organism cannot be ruled out with a very low or even normal CSF WBC count.

Rapid bacteriologic identification is essential as *E. meningosepticum* is typically resistant to the common antimicrobials used to empirically treat Gram-negative rod infections. MALDI-TOF Mass Spectrometry (MS) technology provided the diagnosis within 24 h of admission. Its utility in protein profiling has emerged as a powerful tool for the rapid identification of bacteria and yeast isolates.^[@bib12]^ MALDI-TOF MS can be performed very quickly, requiring a mean of a few minutes per sample to identify an isolate, and with high accuracy.^[@bib13]^ In this case, MALDI-TOF VMS aided management by providing an early identification of an unusual and inherently resistant organism, allowing adjustment of the antibiotic regimen ([Table 3](#tbl3){ref-type="table"}). The Vitek MS RUO System with SARAMIS database by bioMérieux (Durham, NC, USA) is a research use only MALDI-TOF MS system for rapid detection of bacterial and yeast isolates. The MALDI-TOF VMS analysis was performed by using the Shimadzu instrument and the SARAMIS database originally developed by AnagnosTec GmbH and later acquired by bioMérieux.^[@bib14]^ With this technique, colonies from the bacterial culture plate were placed on disposable VMS target plates (cat. no. 220-99999-FM1; Shimadzu Biotech, Columbia, MD, USA) by using disposable loop, overlaid with 1 µl α-cyano-4-hydroxycinnamic acid matrix (bioMérieux cat. no. 411071), and then air dried before being processed by the spectrometer. The result is a spectral fingerprint which is unique to each species, as the mass peaks reflect ribosomal and other constitutive proteins ([Figure 1](#fig1){ref-type="fig"}). The spectral signature is cross-referenced in a database to identify the organism according to its genus or species. The percent of confidence identification ranged from 76% to 89.9%. Within 24 h, the result was confirmed by conventional method using MicroScan (Siemens, West Sacramento, CA, USA) Gram-negative identification panel with 99.9% probability of *E. meningosepticum* and later by Vitek2 Gram-negative card (bioMerieux). In general, SARAMIS confidence level of ≥75% is acceptable for identification. For confirmation of bacterial identification by conventional method such as MicroScan, the isolate was sent to another laboratory (Dr Xiang-Yang Han of MD Anderson in Houston, TX, USA) for 16S ribosomal RNA sequencing. It was identified as *Elizabethkingia meningoseptica* with a score of 1056 bits (1170) and identities 587/588 (99%). MALDI-TOF MS was performed for all isolates; blood, CSF, tissue, as well as sputum samples, identifying the same bacterium with identical spectrum, as well as antimicrobial susceptibility profile.

Conclusion
==========

*E. meningosepticum* is a virulent pathogen, not only in the immunocompromised host, but also in immunocompetent patients. Clinical and laboratory manifestations of *E. meningosepticum* infections are not pathognomonic; thus, early microbiological diagnosis using emerging automated technology such as MALDI-TOF MS is essential in selecting appropriate therapy. As the available data suggest 81% to 91% of isolates are sensitive to trimethoprim-sulfamethoxazole, levofloxacin and rifampin, early identification could predict the antimicrobial susceptibility pattern and help clinicians to choose the right antibiotics.

![*E. meningosepticum* spectral signature from Vitek MS with SARAMIS RUO software.](emi201316f1){#fig1}

###### Laboratory evaluation

  Test                        Result   Reference range
  --------------------------- -------- --------------------------
  **Chemistry**                         
  Sodium                      131      132--144 mEq/L
  Potassium                   3.7      3.4--5.1 mEq/L
  Chloride                    98       101--111 mEq/L
  Bicarbonate                 17       22--32 mEq/L
  Urea nitrogen               62       8--22 mEq/L
  Creatinine                  3.8      0.4--1.0 mg/dL
  AST                         180      10--42 U/L
  ALT                         70       14--54 U/L
  Alkaline phosphatase        73       38--141 U/L
  Total bilirubin             1.1      0.3--1.6 mg/dL
  Creatine phosphate kinase   4367     38--234 U/L
  **Hematology**                        
  WBC                         9.2      4.0×10^3^--8.5×10^3^ /μL
  %Neutrophils                81       25%--62%
  %Bands                      18       \<13%
  RBC                         4.1      3.9×10^6^--5.2×10^6^ /μL
  Hemoglobin                  11.7     11.5--15.5 g/dL
  Hematocrit                  35.1     35.0%--45.0%
  Platelet count              172      140×10^3^--440×10^3^ /μL
  **Cerebrospinal fluid**               
  WBC                         0        \<11/μL
  RBC                         28       0 μL
  Protein                     67       15--45 mg/dL
  Glucose                     53       40--70 mg/dL

Abbreviations: AST, aspartate aminotransferase test; ALT, alanine aminotransferase; WBC, white blood cell; RBC, red blood cell.

###### Characteristics of *E. meningosepticum meningitis* reported cases in adults

  References   Age, Sex     Underlying condition                                Treatment                                             Outcome   Source
  ------------ ------------ --------------------------------------------------- ----------------------------------------------------- --------- ------------
  [@bib15]     17, Male     Thalassemia major, splenectomy                      Vancomycin for 21 days                                Cured     NR**\***
  [@bib16]     88, Female   Diabetes mellitus, cellulitis                       NR                                                    Died      Community
  [@bib11]     21, Female   Diabetes mellitus                                   Cefepime for 21 days                                  Cured     Community
  [@bib17]     27, Female   Acute myelogenous leukemia                          Rifampicin, piperacillin, ciprofloxacin for 23 days   Cured     Nosocomial
  [@bib18]     −            −                                                   −                                                     −         −
  [@bib19]     NR           Myelography                                         NR                                                    NR        Nosocomial
  [@bib8]      43, Male     NR                                                  Piperacillin, cefoperazone, minocyclineerythromycin   Died      Community
  [@bib20]     56, Female   Pituitary tumor s/p transphenoidal hypophysectomy   Rifampin, cefoperazone, chloramphenicol               Cured     Nosocomial
  [@bib21]     60, Male     Squamous cell cancer s/p resection                  Amikacin, erythromycin for 25d                        Cured     Nosocomial
  [@bib22]     26, Female   CKD, renal transplant, tuberculosis                 Erythromycin                                          Died      Nosocomial
  [@bib23]     66, Female   Acute myelogenous leukemia                          Erythromycin                                          Died      Nosocomial
  [@bib24]     43, Male     Squamous cell cancer s/p irradiation/resection      Ampicillin                                            Cured     Community
  [@bib25]     19, Male     Aplastic anemia                                     Neomycin IV/intrathecal                               Died      Nosocomial
  [@bib26]     33, Male     Pulmonary tuberculosis, malnutrition                Chloramphenicol, erythromycin                         Died      NR
  [@bib27]     NR           Postpartum                                          NR                                                    NR        NR
  [@bib3]      NR           Polycythemia                                        NR                                                    Cured     NR

Abbreviations: CKD, chronic kidney disease; NR, not reported; − unavailable

###### Timeline of bacterial identification

  Day 0                                         Day 1                                             Day 2                                      Day 3                                              Day 4
  --------------------- ----------------------------------------------------- --------------------------------------------- --------------------------------------- -------------------------------------------------------------
  Blood was collected    Blood culture was positive, and subculture to plate   Positive growth, identified by MALDI-TOF MS   Identification by conventional method   Antimicrobial susceptibility testing by conventional method
                                          CSF was collected                    Positive growth, identified by MALDI-TOF MS   Identification by conventional method   Antimicrobial susceptibility testing by conventional method

Abbreviations: CSF, cerebrospinal fluid.
